MicroRNA Signature in Renal Cell Carcinoma

Renal cell carcinoma (RCC) includes 2.2% of all diagnosed cancers and 1.8% of cancer-related mortalities. The available biomarkers or screening methods for RCC suffer from lack of sensitivity or high cost, necessitating identification of novel biomarkers that facilitate early diagnosis of this cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghafouri-Fard, Soudeh, Shirvani-Farsani, Zeinab, Branicki, Wojciech, Taheri, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734191/
https://www.ncbi.nlm.nih.gov/pubmed/33330087
http://dx.doi.org/10.3389/fonc.2020.596359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734191/
https://www.ncbi.nlm.nih.gov/pubmed/33330087
http://dx.doi.org/10.3389/fonc.2020.596359

Ejemplares similares